Overcoming Data Quality and Completeness Challenges in EHR-Based Research

Published on 22/12/2025

How to Address Data Quality and Completeness Issues in EHR-Based Research

Electronic Health Records (EHRs) offer rich datasets for real-world evidence (RWE) generation, but they are not without limitations. Pharma professionals and clinical researchers often face hurdles in the form of missing, inconsistent, or poorly structured data. If unaddressed, these issues can compromise patient safety insights, treatment outcome evaluations, and even regulatory acceptance of study findings.

This guide will walk you through practical strategies to ensure data quality and completeness in EHR-based research for robust, reproducible, and regulatory-compliant outcomes.

Table of Contents

Understanding the Core Data Quality Challenges:

Several recurring problems can affect the reliability of EHR data in clinical trial planning and RWE generation:

Missing or incomplete fields: Unrecorded vitals, demographics, or outcomes reduce analytical power.
Data inconsistencies: Different physicians may document the same diagnosis differently.
Unstructured data: Clinician notes and scanned PDFs are hard to analyze without NLP tools.
Coding variations: Use of outdated or localized ICD/SNOMED codes affects interoperability.
Delayed data entry: Time lags reduce the value of real-time surveillance.

As per EMA guidelines, RWE studies must clearly document how data quality was verified and managed prior to inclusion in study results.

Step-by-Step Solutions to Improve EHR Data

Quality:

Assess Data Completeness Before Study Start:

Run exploratory data analysis to calculate the percentage of missing values across critical fields such as age, diagnosis, medication, and lab values. Set thresholds for acceptable completeness (e.g., ≥90%).
Use Common Data Models (CDMs):

Adopt models like OMOP or Sentinel to standardize variables and facilitate mapping across systems. This minimizes ambiguity and improves cross-site comparisons.
Implement Automated Validation Rules:

Use algorithms to detect outliers, duplicates, or biologically implausible values (e.g., systolic BP = 20 mmHg). These automated flags are part of effective GMP documentation practices for informatics tools.
Audit Structured vs Unstructured Data:

Conduct manual chart reviews to estimate the proportion of usable data captured in structured fields vs free text. Invest in NLP only if the unstructured portion is significant and relevant.
Clarify Time Stamps and Event Sequencing:

Ensure every clinical event (admission, lab test, discharge) has accurate and machine-readable timestamps. Inconsistent timing can skew temporal analyses, especially in outcomes research.
Apply Data Provenance Tags:

Track the origin and transformation of each data point—from source system to final analytical variable. This traceability supports GCP and regulatory compliance.

Tools and Technologies for EHR Data Validation:

Several tools can automate data validation, improve completeness, and clean EHR data:

REDCap: Widely used for collecting structured data and verifying EHR imports.
OHDSI’s Achilles: Performs automated data quality checks on OMOP CDM databases.
SAS DataFlux: Enterprise-grade tool for cleaning and standardizing datasets.
Python & Pandas: Popular scripting tools to apply custom data validation logic.

When implementing these tools, ensure the audit trails are in place, aligning with Pharma SOP examples for electronic data integrity.

Real-World Case Study: Improving Diabetes Dataset Quality

In a real-world study on Type 2 Diabetes, researchers faced 35% missing HbA1c values. A root cause analysis revealed these were entered in physician notes, not structured lab fields. By deploying an NLP engine and retraining staff, completeness rose to 92%—enhancing statistical power and regulatory acceptance.

This emphasizes that StabilityStudies.in methodology applies not only to chemical data but also to digital health records.

Monitoring and Continuous Improvement:

Set Data Quality KPIs: Monitor missingness rates, inconsistency ratios, and time-to-entry metrics.
Establish Feedback Loops: Share data quality dashboards with clinical data entry teams.
Run Quarterly Audits: Sample records for manual review and validate against source documents.
Document Corrections: Keep a detailed log of cleaning steps, transformations, and imputation methods.

Continuous monitoring aligns with pharmaceutical validation practices and supports future inspections or publications.

Ethical Considerations in Data Management:

Ensure de-identified patient data remains anonymous through the entire quality pipeline.
Communicate data quality limitations transparently in study publications and reports.
Respect data access boundaries set by institutional review boards and consent protocols.

As per Health Canada, incomplete datasets used in drug safety evaluations may result in regulatory warnings or rejections. Therefore, proactive quality control is critical.

Conclusion: Make Data Quality a Strategic Asset

In the era of data-driven decision-making, the integrity and completeness of your EHR datasets are paramount. By implementing robust validation protocols, leveraging automated tools, and maintaining regulatory transparency, clinical and RWE studies can stand up to scrutiny and deliver trustworthy insights.

Pharma professionals must treat EHR data quality not as a bottleneck, but as a strategic pillar of evidence generation—essential for the credibility of findings and patient safety alike.